233 search results for “drug delivery” in the Staff website
-
Active learning
Didactics
-
CCLS Seminar
Lecture, Center of Computational Life Sciences
-
Organ failure caused by viruses, how does it work? Now there are methods to find out
Dying from viral infection due to organ failure and blood loss: we still know little about how it can happen. Among other things, Huaqi Tang developed an organ-on-a-chip to figure it out. 'These technologies can offer unprecedented opportunities to fight the viruses that threaten our society.' Tang…
-
Room for everyone at a sun-drenched EL CID
Thousands of first-year students and hundreds of mentors kicked off the EL CID on Monday morning. This year for the first time, the introduction week of Leiden University and Leiden University of Applied Sciences was also open for students of Regional Training Centre mboRijnland and the Leiden Instrument…
-
Using low sample volumes to better understand brain diseases
Marlien van Mever delved into the analysis of tiny samples, cerebrospinal fluid from transgenic mouse models for example. She validated methods that can now be used to study brain diseases such as migraine and epilepsy. Van Mever will receive her PhD on 14 June.
-
Minor Violence Studies: interesting encounters and flying wooden blocks
The English taught interdisciplinary minor Violence Studies looks into various facets of interpersonal violence. Is this minor for all Leiden students? These two 'colleagues' are certain of it.
-
Veni grant for ten Leiden researchers
Ten Leiden researchers have been awarded a Veni grant by the Dutch Research Council (NWO). The grant, of up to 280,000 euros, will enable them to elaborate their ideas over a period of three years.
-
‘Ultimately, the goal is to develop antibiotics for tuberculosis with a lower risk of resistance’
Tuberculosis stands as one of the most lethal infectious diseases worldwide. A significant challenge in combatting tuberculosis lies in the emergence of antibiotic resistance triggered by genetic alterations, commonly known as mutations. These mutations can diminish the responsiveness to antibiotics,…
-
How NeCEN helped develop the Johnson & Johnson Covid-19 vaccine
The Phase 3 clinical trial results of the promising Covid-19 vaccine of Johnson & Johnson are expected this month. The Dutch electron microscopy facility NeCEN helped develop the company’s vaccine, and they have now published their scientific findings in Nature Communications.
-
How to make cryptographic techniques more efficient?
Sharing scientific data, transferring money, or sending other sensitive information online: with cryptography, applications make sure your data does not fall into the wrong hands. Mathematician Thomas Attema (CWI/TNO/Leiden University) helps with this. For his PhD research, he developed a new technique…
-
With 30 million dollars, this consortium aims to tackle tuberculosis
Thanks to a clever research method, progress is being made in the quest for better tuberculosis medications. Within an American consortium that received a 30 million dollars grant, Leiden researcher Rob van Wijk plays a significant role. ‘The next breakthrough in tuberculosis research will come much…
-
Post-quantum cryptography should keep our DigiD, bank accounts and state secrets safe
Our banking, DigiD and sensitive medical data: what if our entire digital infrastructure can no longer be trusted? Jelle Don has this question permanently in mind as he goes about his research. And that is no bad thing because without new digital security measures, our society will be extremely vuln…
-
Biological Origami at molecular level: folding a single protein
Human cells are protecting their proteins from unfolding and aggregating. That's what biophysicist Alireza Mashaghi and his team discovered after seven years of in-depth research into the folding mechanisms of proteins. With an unprecedented approach, the team was able to study the folding of a single…
-
'Satisfied students give me more fulfillment than getting a research grant'
Imparting students with a critical attitude and cross-curricular skills. That is what Rawi Ramautar wants to strive for as the new programme director (OD) of the bachelor of Bio-Pharmaceutical Sciences. 'A programme director has to create a programme of which students say: I find it challenging and…
-
Curing diseases with lab-grown organs
Organs and tissues grown in the lab may in the future be able to cure people with organ failures. Micha Drukker, professor of Stem Cells, Developmental Biology and Technology for Innovative Drug Research, is convinced that the use of stem cells will make this possible. He will deliver his inaugural…
-
New statistical method brings together studies at an early stage
During the coronavirus pandemic, scientists were in a hurry to find drugs that would help fight the disease. To combine the research that was being carried out around the world, PhD candidate Judith ter Schure developed a new statistical method: ALL-IN meta-analysis. This helps determine sooner whether…
-
Awaken sleeping antibiotics with ERC Advanced grant
To facilitate the search for new antibiotics. That is the aim of Gilles van Wezel, professor molecular biotechnology at the Institute of Biology Leiden (IBL). He wants to do this by looking at similarities in the DNA of antibiotic-producing bacteria. Van Wezel has been awarded an ERC Advanced grant…
-
10th Life Science Symposium
Conference
-
Leiden2022 Life Sciences and Health Week
Conference
-
Seminar: POPNET Connects with Ozan Candogan
Lecture
-
Stronger together: the Leiden Research Support Network
The academic playing field is becoming more complex all the time, making a strong research support network crucial. Over 100 research support professionals shared knowledge, gained inspiration and became acquainted or got to know each other even better at the third Leiden Research Support Conference…
-
‘Looking back, this past year will be a very important period in my life’
At the Faculty of Science, forty per cent of the employees are of a non-Dutch nationality. Amongst PhDs that is even sixty per cent. How are they doing in a time of working at home in a different culture, when travelling is not possible? Clinical pharmacologist Lu Chen is the third in this series to…
-
Leiden University celebrates curiosity at 449th Dies Natalis
How has evolution shaped our curiosity? And how does that curiosity ensure that we now have the technological ability to discover whether we are alone in the universe? This was all covered during the celebration of Leiden University’s 449th Dies Natalis.
-
How do we prepare students for jobs that don’t yet exist?
We can accrue pensions, reinforce dykes and make our homes more sustainable. But how do we make our higher education fit for the future? And what skills should we be teaching our students now for jobs that don’t yet exist? Lecturers and educational developers looked to the future during the keynote…
-
‘Science is international so our faculty should be too’
‘Our faculty is a very international community. And that is something everybody really benefit from,’ says Yun Tian. As the officer internationalisation, she is the bridge between international students and staff, the faculty and universities abroad. ‘Science goes beyond countries and carries no nationality.…
-
Global Impact in Health Symposium
Symposium | Leiden2022
-
Learning Unkown Intervention Targets in Structural Causal Models
Lecture
-
Bioengineering and Biophysics of Viral Hemorrhagic Fever
PhD defence
- IBL Symposium 2022
-
Innovating and connecting
447th Dies Natalis
-
Alumna Natacha Harlequin: ‘When it really matters, I’m a lion’
She stands out for the moderate tone she takes in discussions on Dutch talk shows. Without judgement you can have an open conversation, criminal lawyer Natacha Harlequin learned in her student days in Leiden. ‘What I personally think of the alleged act doesn’t matter so much.’
-
Researchers from Leiden visit Indonesia on knowledge mission
A delegation from Leiden University recently embarked on a knowledge mission to various NGOs, universities and government organisations in Indonesia. New partnerships were formed and important knowledge exchanged, and researchers from Leiden gave guest lectures.
-
‘We couldn't really celebrate our vaccine being approved, but we were over the moon’
On 11 March, pharmaceutical company Janssen received approval to launch its corona vaccine on the European market. This made Janssen the fourth company to be given the green light by the European Medicines Agency. As Lead of the Janssen Campus in the Netherlands, Biology alumnus Bart van Zijll Langhout…